Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults

NCT05972733 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

HilleVax